Gainers
- Ayala Pharmaceuticals, Inc. (NASDAQ:AYLA) rose 64.4% to $1.43 in pre-market trading. Ayala Pharmaceuticals filed request for withdrawal of registration statement on form S-1.
- McEwen Mining Inc. (NYSE:MUX) rose 36.5% to $0.4450 in pre-market trading.
- Humanigen, Inc. (NASDAQ:HGEN) rose 25% to $0.5163 in pre-market trading after declining around 5% on Monday.
- Code Chain New Continent Limited (NASDAQ:CCNC) rose 13.9% to $0.3495 in pre-market trading after dropping over 19% on Monday.
- STRATA Skin Sciences, Inc. (NASDAQ:SSKN) rose 12.7% to $1.24 in pre-market trading after the company announced U.S. commercial launch of TheraClearX Acne Therapy System.
- GeoVax Labs, Inc. (NASDAQ:GOVX) rose 11.9% to $1.78 in pre-market trading. GeoVax Labs shares jumped 150% on Monday on news that WHO has declared Monkeypox a public health emergency over the weekend.
- Redbox Entertainment Inc. (NASDAQ:RDBX) rose 11.5% to $6.19 in pre-market trading after jumping 82% on Monday.
- Sundial Growers Inc. (NASDAQ:SNDL) rose 11% to $3.30 in pre-market trading following effect of 1:10 reverse stock split.
- TOMI Environmental Solutions, Inc. (NASDAQ:TOMZ) rose 10.4% to $0.85 in pre-market trading after gaining around 17% on Monday.
- Scopus BioPharma Inc. (NASDAQ:SCPS) rose 10% to $0.4290 in pre-market trading.
- BuzzFeed, Inc. (NASDAQ:BZFD) rose 9.5% to $1.96 in pre-market trading. BuzzFeed is expected to release Q2 earnings on August 9, 2022.
- Shell Midstream Partners, L.P. (NYSE:SHLX) rose 9.3% to $15.90 in pre-market trading. Shell USA, Inc. and Shell Midstream Partners, L.P. reached a definitive merger agreement.
- F5, Inc. (NASDAQ:FFIV) rose 7.5% to $166.07 in pre-market trading after reporting upbeat Q3 results.
- Alibaba Group Holding Limited (NYSE:BABA) rose 4.4% to $105.40 in pre-market trading as the company said Tuesday it plans to apply for a primary listing in Hong Kong. The stock already has a secondary listing in Hong Kong, which is a special administrative region of China.
Don’t forget to check out our premarket coverage here .
Losers
- Revelation Biosciences, Inc. (NASDAQ:REVB) shares fell 37.6% to $0.63 in pre-market trading. Revelation Biosciences shares jumped 55% on Monday after the company announced the data from its Phase 1b CLEAR clinical study of REVTx-99b met the primary endpoint.
- The Aaron's Company, Inc. (NYSE:AAN) fell 24.8% to $11.65 in pre-market trading after the company lowered its sales guidance for the full year.
- Koss Corporation (NASDAQ:KOSS) fell 15.2% to $9.50 in pre-market trading. Koss shares jumped 45% on Monday following a Bloomberg Law report titled "Apple, Koss Reach Deal in AirPods Patent Case on Eve of Trial."
- NewAge, Inc. (NASDAQ:NBEV) shares fell 13.7% to $0.25 in pre-market trading. NewAge recently announced the departure of CFO Kevin Manion.
- ToughBuilt Industries, Inc. (NASDAQ:TBLT) fell 13.5% to $5.08 in pre-market trading. ToughBuilt Industries shares dipped 26% on Monday after the company announced a $20 million private placement priced at a premium to market under Nasdaq rules.
- Golden Sun Education Group Limited (NASDAQ:GSUN) shares fell 12.8% to $27.00 in pre-market trading after gaining 9% on Monday.
- Vinco Ventures, Inc. (NASDAQ:BBIG) fell 10.5% to $0.8949 in pre-market trading. Vinco Ventures postponed stockholder meeting from July 26, 2022 to August 23, 2022.
- Bright Scholar Education Holdings Limited (NYSE:BEDU) fell 10.1% to $0.80 in pre-market trading. Bright Scholar Education is expected to release its unaudited financial results for the third fiscal quarter of fiscal 2022 ended May 31, 2022, on August 4, 2022.
- Virax Biolabs Group Limited (NASDAQ:VRAX) fell 9.5% to $15.20 in pre-market trading after jumping around 62% on Monday.
- Walmart Inc. (NYSE:WMT) shares fell 9.3% to $119.69 in pre-market trading after the company cut guidance for the second quarter and full fiscal year. Walmart said it revised its outlook as a result of pricing actions aimed to improve inventory levels at Walmart and Sam's Club in the U.S. and mix of sales.
- Carter's, Inc. (NYSE:CRI) fell 7.7% to $72.83 in pre-market trading.
